Ajibade Ashaye M.D.

Ajibade Ashaye MD MBA currently serves as the Director and Team Lead for Global Evidence & Outcomes in Leukemia, Lymphoma, and Lung Cancer at Takeda Oncology, a position held since March 2018. Additional roles include Board Observer at Surgicure Technologies, Inc., Founding Managing Partner at BakerBridge Capital, and Investor at BakerBridge Holdings. Ajibade has also contributed as an Assistant Professor at Tufts University School of Medicine, directing graduate courses in Healthcare Analytics, and held various positions at Evidera, Hartford Hospital, and the University of Connecticut. Educational credentials include an MBA from Imperial Business School, an M.D. from the University of Ibadan, and multiple degrees in Health Services Research and Public Health from Boston University, as well as a credential from Harvard Business School Online. Ajibade's expertise encompasses health economics, outcomes research, and oncology.